Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
出版年份 2020 全文链接
标题
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
作者
关键词
-
出版物
Cancers
Volume 12, Issue 3, Pages 643
出版商
MDPI AG
发表日期
2020-03-12
DOI
10.3390/cancers12030643
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Childhood cerebellar tumours mirror conserved fetal transcriptional programs
- (2019) Maria C. Vladoiu et al. NATURE
- Resolving medulloblastoma cellular architecture by single-cell genomics
- (2019) Volker Hovestadt et al. NATURE
- Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
- (2019) Liguo Zhang et al. CANCER CELL
- Towards Immunotherapy for Pediatric Brain Tumors
- (2019) Stacie Shiqi Wang et al. TRENDS IN IMMUNOLOGY
- Medulloblastoma in the age of molecular subgroups: a review
- (2019) Kyle Juraschka et al. Journal of Neurosurgery-Pediatrics
- A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases
- (2018) Livia Garzia et al. CELL
- A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
- (2018) Soledad Gómez et al. CLINICAL CANCER RESEARCH
- Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis
- (2018) Maria Łastowska et al. JOURNAL OF NEURO-ONCOLOGY
- Epigenetic regulation in medulloblastoma
- (2018) Jiaqing Yi et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Infant medulloblastoma — learning new lessons from old strata
- (2018) Marc Remke et al. Nature Reviews Clinical Oncology
- Structural variation in the 3D genome
- (2018) Malte Spielmann et al. NATURE REVIEWS GENETICS
- Subgroup-specific immune and stromal microenvironment in medulloblastoma
- (2018) Michael Bockmayr et al. OncoImmunology
- Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
- (2018) Antoine Forget et al. CANCER CELL
- Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
- (2018) Tenley C. Archer et al. CANCER CELL
- MR Imaging–Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma
- (2018) M. Iv et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Medulloblastoma: From Myth to Molecular
- (2017) Vijay Ramaswamy et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013
- (2017) Vishesh Khanna et al. JOURNAL OF NEURO-ONCOLOGY
- Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
- (2017) Edward C Schwalbe et al. LANCET ONCOLOGY
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
- (2017) Giles W. Robinson et al. Oncotarget
- Understanding medulloblastoma
- (2017) Alyssa Quinlan et al. JAAPA-Journal of the American Academy of Physician Assistants
- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
- (2016) Timothy N. Phoenix et al. CANCER CELL
- Impact of the physical microenvironment on tumor progression and metastasis
- (2016) Fabian Spill et al. CURRENT OPINION IN BIOTECHNOLOGY
- Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
- (2016) Eric M Thompson et al. LANCET ONCOLOGY
- Active medulloblastoma enhancers reveal subgroup-specific cellular origins
- (2016) Charles Y. Lin et al. NATURE
- Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin
- (2016) Benjamin Z Stanton et al. NATURE GENETICS
- Dynamics of BAF–Polycomb complex opposition on heterochromatin in normal and oncogenic states
- (2016) Cigall Kadoch et al. NATURE GENETICS
- Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
- (2015) C. D. Pham et al. CLINICAL CANCER RESEARCH
- Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
- (2015) Giles W. Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Subgroup-specific localization of human medulloblastoma based on pre-operative MRI
- (2014) Annika K. Wefers et al. ACTA NEUROPATHOLOGICA
- MRI Surrogates for Molecular Subgroups of Medulloblastoma
- (2014) S. Perreault et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- (2014) Marcel Kool et al. CANCER CELL
- Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas
- (2014) A. S. Margol et al. CLINICAL CANCER RESEARCH
- Cytogenetic Prognostication Within Medulloblastoma Subgroups
- (2014) David J.H. Shih et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
- (2014) Paul A. Northcott et al. NATURE
- Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
- (2014) Volker Hovestadt et al. NATURE
- DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
- (2013) Edward C. Schwalbe et al. ACTA NEUROPATHOLOGICA
- The Role of Chromatin Remodeling in Medulloblastoma
- (2013) David T. W. Jones et al. BRAIN PATHOLOGY
- Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
- (2013) A. Gajjar et al. CLINICAL CANCER RESEARCH
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)
- (2013) Kevin C. De Braganca et al. Current Treatment Options in Neurology
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Subgroup-Specific Prognostic Implications ofTP53Mutation in Medulloblastoma
- (2013) Nataliya Zhukova et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
- (2013) Vijay Ramaswamy et al. LANCET ONCOLOGY
- Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics
- (2013) N.V. Batora et al. NEUROSCIENCE
- Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
- (2012) Adrian M. Dubuc et al. ACTA NEUROPATHOLOGICA
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
- (2012) Trevor J. Pugh et al. NATURE
- Novel mutations target distinct subgroups of medulloblastoma
- (2012) Giles Robinson et al. NATURE
- Dissecting the genomic complexity underlying medulloblastoma
- (2012) David T. W. Jones et al. NATURE
- Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
- (2011) Paul A. Northcott et al. ACTA NEUROPATHOLOGICA
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
- (2011) Paul A. Northcott et al. ACTA NEUROPATHOLOGICA
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Adult Medulloblastoma Comprises Three Major Molecular Variants
- (2011) Marc Remke et al. JOURNAL OF CLINICAL ONCOLOGY
- esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function
- (2011) Lena Ho et al. NATURE CELL BIOLOGY
- Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease
- (2010) David W. Ellison ACTA NEUROPATHOLOGICA
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation-induced Glioblastoma Multiforme in Children Treated for Medulloblastoma With Characteristics of Both Medulloblastoma and Glioblastoma Multiforme
- (2010) Jennifer R. Madden et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Subtypes of medulloblastoma have distinct developmental origins
- (2010) Paul Gibson et al. NATURE
- The Genetic Landscape of the Childhood Cancer Medulloblastoma
- (2010) D. W. Parsons et al. SCIENCE
- Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations
- (2009) L. Brugieres et al. JOURNAL OF MEDICAL GENETICS
- Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
- (2009) Paul A Northcott et al. NATURE GENETICS
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of and Prognosis With Medulloblastoma
- (2008) Roger J. Packer et al. ARCHIVES OF NEUROLOGY
- Medulloblastoma Can Be Initiated by Deletion of Patched in Lineage-Restricted Progenitors or Stem Cells
- (2008) Zeng-Jie Yang et al. CANCER CELL
- Wnt/β-catenin signaling controls development of the blood–brain barrier
- (2008) Stefan Liebner et al. JOURNAL OF CELL BIOLOGY
- Radiation-induced glioblastoma in a medulloblastoma patient: A case report with molecular features
- (2008) Marco Gessi et al. NEUROPATHOLOGY
- Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
- (2008) Marcel Kool et al. PLoS One
- Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma
- (2007) Thomas E. Merchant et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started